Equity Markets

We present a summary of changes in key Indian & Global equity indices.

Performance:
Duration Nifty 50 Nifty Midcap 100 Nifty Small Cap 100 Dow Jones Indus. Avg S&P 500 Index Nasdaq Composite Index
1 Month 5.5% 2.5% 2.6% 14.1% 8.1% 4.0%
1 Year 3.4% 4.6% -9.02% -6.7% -14.6% -28.5%

Source: Bloomberg; Data as on October 30th, 2022

Indian markets continued its rally during the month, and this time the US markets led the rally with a big up move in the Dow Jones and S&P 500 Index. Amidst all the volatility of last six months, Nifty & Midcap indices are closer to their all their time highs with only the Small cap indices materially lower. Amidst the geopolitical tensions and energy/food crisis that the world is facing currently, India seems to be emerging as a safe haven and despite rich valuations, we are seeing India markets continue to outperform regional and global markets on annual basis.

Indian markets rallied with Nifty 50 Index being the best-performing and mid and smallcap indices being up similarly. Sector-wise Financials, IT and Auto outperformed while FMCG, Pharma & Metals underperformed the Nifty 50 Index. Global markets outperformed India this month.

As global markets stabilized, and we saw US yields falling off their highs, the FII flows started turning and we have Rs 8,300Crs of inflows versus the sharp outflows seen in September (~ Rs 13,400Crs). The FPI flows are yet volatile and globally the sentiments remain weak as fear of aggressive Fed rate hikes and liquidity withdrawal continue to keep everyone on tenterhooks.

Result season so far has been better than estimates with few sectors like Financials, IT and Auto doing much better with potential earnings upgrades. FMCG sector continues to get hit by weak rural demand and high RM inventory impacting margins for the quarter. Few sectors like commodities (metals and cement) and Oil & Gas sector are also showing material weakness from drop in prices.

Festive month of October has been strong with good demand across product categories as Diwali is celebrated free of Covid restrictions after two years. Rural India continues to underperform urban India currently, but we believe the Rabi season will start to see recovery.

Indian economy continues to be an oasis amid global slowdown as the reforms rolled out in the last few years start to yield results on tax collections front, as well as aid our external account by improving self-reliance. There is some pressure on energy prices front and fear of FPI outflows that has weakened the INR. However, India has managed one of the most controlled depreciation of the currency in the midst of a global crisis with INR outperforming against EUR/GBP and JPY.

Looking Ahead

Global data points have started to weaken and there is a hope that the US Fed may be closer to its target rate. With economy slowing down its highly likely that Fed may be willing to review its stance. The US yield curve has inverted, and some section of market has again started to hope for a Fed pivot. We believe Fed’s action are likely to have direct implications on risk appetite & valuations and hence a good strategy for investors is to focus on asset allocation. Systematic Investment Paln (SIP) might remain a preferred way to increase equity allocation using market volatility.

Indian economy remains on a growth path leading the world economic growth ranking. The results so far in Q2FY23 have been good and even though commentary has started to turn cautious, downgrades to FY23 estimates are restricted to commodity sector. Amidst the uncertainties, our investment approach remains focussed on selecting companies; with near-term earnings growth, positioned as market leaders in their respective industries, with low leverage on balance-sheets and with pricing power.

Asset allocation to equities creates wealth over long term as growth rewards equity assets. Growth outlook turns volatile at various times due to multiple factors. History has shown that equity assets acquired during volatile times deliver better returns over longer term. We recommend

    1. Conservative investors may continue to use systematic investment route and avoid the market timing worries.
    2. Aggressive investors may attempt market timing via lumpsum investments.
    3. Balance investors may use “Balanced Advantage route”. This allows fund managers the flexibility of shifting asset allocation and time the market during volatility.




Scheme Strategy - Equity Schemes
  • Mahindra Manulife Multi Cap Badhat Yojana
  • Mahindra Manulife Mid Cap Unnati Yojana
    • This scheme would aim to invest in companies that demonstrate higher earnings growth outlook , potential of rerating  or sectoral leadership position which can take advantage of the India’s growth story. The portfolio will invest predominantly in mid-cap stocks (>65%) apart from some exposure to small and large-cap stocks. The portfolio will have a mix of top-down and bottom-up approach to investing.
  • Mahindra Manulife ELSS Kar Bachat Yojana
    • The portfolio has allocation to stocks across market capitalization and may focus on companies that have the power to take advantage of the opportunities the economy offers. The stocks in the portfolio are likely to have a superior product line, manageable debt and leadership in their respective sectors.
  • Mahindra Manulife Flexi Cap Yojana
    • The Scheme follows top down sector allocation and bottom up stock selection ideas that may benefit based on health of economy. Allocation across marketcaps is a function of economic outlook, domestic liquidity and stage of market cycle. Focus will be on high quality, growth focussed companies available at reasonable valuations.
  • Mahindra Manulife Rural Bharat and Consumption Yojana
    • The portfolio is a concentrated portfolio and aims to have a rural bias and look for opportunities in rural consumption, rural infrastructure and rural lending.
  • Mahindra Manulife Large Cap Pragati Yojana
    • The portfolio is a concentrated portfolio with a top-down approach would be adopted to identify sectors with potential across different periods based on emerging macro trends. In addition, a bottom-up stock selection would also be followed, to identify companies with earnings growth potential, strong balance sheet and good governance.
  • Mahindra Manulife Top 250 Nivesh Yojana
    • The scheme focusses on investing in companies that have demonstrated strong leadership and sustained growth and continue to do so. The portfolio currently has around 53%,38% and 5% of net equity holdings in large, mid and small cap respectively.
  • Mahindra Manulife Focused Equity Yojana

      The Scheme focuses on maintaining an appropriate diversified portfolio of companies with a medium term perspective. The Scheme follows a top down approach to select sectors and a bottom up approach to pick stocks across the sectors based on the quality of business model and quality of management. Quality of business model and quality of management will be assessed by evaluating past track record and/or future outlook. The selection of companies will be guided by a combination of one or more factors like:

      1. Growth opportunities
      2. Cash flows generated and ability to finance the growth.
      3. Management quality to deliver the growth.
Scheme Specific Strategies for Hybrid Schemes
  • Mahindra Manulife Equity Savings Dhan Sanchay Yojana

    Equity:

    • Portfolio composition would have preference for growth style of investing.
    • Bottom-up approach would be adopted to identify companies that have ability to scale up, gain market share and/or are present in sunrise/high growth sectors.
  • Mahindra Manulife Hybrid Equity Nivesh Yojana

    Equity:

    • Macro theme of the portfolio will be to identify the status of economy and invest in sectors with potential to outperform.
    • Portfolio composition would have preference for companies with potential for earnings upgrade and possible valuation upgrades as well.


    Debt:

    • The Modified duration of the portfolio is around 2.04 years for the debt portion.
    • We have now a larger allocation to gilts than credits and may maintain this stance in the near future.
  • Mahindra Manulife Balanced Advantage Yojana

    Equity:

    • Portfolio composition would have preference for growth style of investing with large cap bias.
    • Bottom-up approach would be adopted to identify companies that have ability to scale up, gain market share and/or are present in sunrise/high growth sectors.


    Debt:

    • The Modified duration of the portfolio is around 1.99 years for the debt portion.
    • The duration is built through exposure in 10-year/5-year Gilt.
What should an investor do?

For investments in equity oriented products:

  • Our view is that volatility may continue and SIP may be a good way to increase equity market allocations.
  • Investors looking to invest for a medium to long period, may consider SIPs or STPs into focused, multicap or hybrid funds based on risk appetite.
  • Investors looking for a better return opportunity and with a suitable risk appetite, may consider part allocation in mid cap fund as well.
Bond And Money Market

We present a matrix detailing movement in some key market rates (domestic and global) and key events:

Parameters 31st October 22 30th September 22 31th October 21
RBI Repo Rate % 5.90 5.90 4.00
5Y AAA PSU % 7.40 7.34 5.99
1 year CD % 7.50 7.05 4.31
10Y Gsec % 7.45 7.40 6.39
CPI (%) 7.41 7.00 4.48
IIP (YoY) % -0.83 2.36 4.17
US 10Y % 4.05 3.83 1.55
Dollar Rupee 82.79 81.35 74.88

Source: Bloomberg; Data as on October 31st, 2022.

The domestic debt market continued to witness a schism in the yield curve. The money market yields moved up by close to 40-50 basis points (bps) while the benchmark 10 year Gilt rates remained largely stable and moved up by around 5 bps . A tight systemic liquidity coupled with supply from the banking segment in issuing Certificate of Deposits (CDs) to fund the strong credit growth led to a sharp rise in the short-term rates. The credit yields curve for AAA rated issuers has largely become flat now with the 1, 3 and 10 year rates largely the same now.

As minutes of the MPC meeting held on September 30th were put out for in the public domain, we saw two external members opining for a wait and watch policy to see the lag effects on the economy of the monetary policy measures.

The US rates continued its upward trend and the yield curve from the 3 month treasury to the 10 year treasury flattened marking potential recessionary economic growth in the near future .The home prices in the US have started stagnating /marginally falling and this trend would be actively monitored . The US Fed meets in the first week of November and would be an interesting watch.

Looking Ahead
  • We think the domestic rate cycle is close to its peak. While RBI may have a bit more rate hike cycle up its sleeve, the markets have largely priced in such rate hikes. With RBI projecting an inflation of 5% in the second quarter of fiscal 2024, the time is now apt for looking into fixed income products across all duration segments .With commodity prices, barring crude, softening through the past 3 months ; we think a sustained commodity slowdown will provide a respite to the retail inflation.
  • The bear flattening of the yield curve specially in the 1-5 year segment has largely happened hinting at the possible end of the upward movement of the domestic rate trajectory.
  • We also believe that AAA credit spreads are very tight and the probability of spreads to increase soon remains a distinct possibility.
  • Liquidity being gradually normalized, the extreme short end of the yield curve may l also remain under pressure.
  • With US Fed trying to engineer a soft landing to the economy, there has been historically no precedence of inflation remaining high after recession , which possibly also bodes well for fixed income allocation.
What should an investor do?

  • We believe that investors with a shorter-time horizon of less than one year may continue investments in ultra-short term and low duration funds.
  • Short-term fund category may be suitable for investors looking to stay for a time horizon beyond one year with lower risk volatility.
  • For a long investment horizon and with a suitable risk appetite, an allocation to Dynamic Bond fund merits attention.
Scheme strategy – Debt Schemes
  • Mahindra Manulife Low Duration Fund
    • The average maturity is around 262.44 days.
    • The YTM of the portfolio is increased to 7.32%.
    • With our view on Gsec possibly offering better opportunities than Bonds, we derive around 30% of our duration through Gsecs in this fund.
    • We would remain skewed in this duration range as the RBI has started the hike cycle.
    • Potential Risk Classification (PRC)
      Potential Risk Class Matrix (Maximum risk the Scheme can take)
      Credit Risk Relatively Low (Class A) Moderate (Class B) Relatively High (Class C)
      Interest rate Risk
      Relatively Low (Class I) B-I
      Moderate (Class II)
      RelativelyHigh (Class III)
  • Mahindra Manulife Ultra Short Term Fund
    • The average maturity of the portfolio is around 139.41 days.
    • We will remain in this maturity segment as we move ahead through the next month.
    • The YTM of the portfolio is around 7.14%.
    • Potential Risk Classification (PRC)
      Potential Risk Class Matrix (Maximum risk the Scheme can take)
      Credit Risk Relatively Low (Class A) Moderate (Class B) Relatively High (Class C)
      Interest rate Risk
      Relatively Low (Class I) B-I
      Moderate (Class II)
      Relatively High (Class III)
  • Mahindra Manulife Liquid Fund
    • We continue to maintain a healthy mix of certificate of deposits and commercial papers.
    • We will attempt to ensure adequate liquidity, safety and accrual.
    • Potential Risk Classification (PRC)
      Potential Risk Class Matrix (Maximum risk the Scheme can take)
      Credit Risk Relatively Low (Class A) Moderate (Class B) Relatively High (Class C)
      Interest rate Risk
      Relatively Low (Class I) B-I
      Moderate (Class II)
      Relatively High (Class III)
  • Mahindra Manulife Dynamic Bond Yojana
    • The YTM of the portfolio has is around 7.23%.
    • The Modified Duration of the portfolio (MD) is maintained around 3.38 years.
    • The Portfolio largely derives it duration from Gilts as we believe that the AAA credit spreads may expand as we move ahead.
    • Potential Risk Classification (PRC)
      Potential Risk Class Matrix (Maximum risk the Scheme can take)
      Credit Risk Relatively Low (Class A) Moderate (Class B) Relatively High (Class C)
      Interest rate Risk
      Relatively Low (Class I)
      Moderate (Class II)
      Relatively High (Class III) B-III
  • Mahindra Manulife Short Term Fund
    • The YTM of the portfolio is around 7.27%.
    • The Modified duration of the portfolio is around 1.82 years and we would keep this duration going ahead.
    • Our portfolio continues to have a large allocation towards gilts, accounting for around 50% of the duration as we are wary of the spreads increasing in AAA credits.
    • Potential Risk Classification (PRC)
      Potential Risk Class Matrix (Maximum risk the Scheme can take)
      Credit Risk Relatively Low (Class A) Moderate (Class B) Relatively High (Class C)
      Interest rate Risk
      Relatively Low (Class I)
      Moderate (Class II) B-II
      Relatively High (Class III)
Scheme Name Product Suitability Scheme Riskometer Scheme Benchmark Benchmark Riskometers
Mahindra Manulife Multi Cap Badhat Yojana
(Multi Cap Fund - An open-ended equity scheme investing across large cap,mid cap, small cap stocks)
This Product is suitable for investors who are seeking*:
  • Medium to Long term capital appreciation.
  • Investment predominantly in equity and equity related securities including derivatives.
  • Investors should consult their financial advisers if in doubt about whether the product is suitable for them.
Investors understands that their principal will be at Very High risk
Nifty 500 Multicap 50:25:25 Index TRI
Mahindra Manulife Mid Cap Unnati Yojana
(Mid Cap Fund – An open ended equity scheme predominantly investing in mid cap stocks)
This Product is suitable for investors who are seeking*:
  • Long term capital appreciation.
  • Investment predominantly in equity and equity related securities including derivatives of mid cap companies.
  • Investors should consult their financial advisers if in doubt about whether the product is suitable for them.
Investors understands that their principal will be at Very High risk
Nifty Midcap 150 TRI
Mahindra Manulife ELSS Kar Bachat Yojana
(An open ended equity linked savings scheme with a statutory lock in of 3 years and tax benefit)
This Product is suitable for investors who are seeking*:
  • Long term capital appreciation
  • Investment predominantly in equity and equity related securities.
  • Investors should consult their financial advisers if in doubt about whether the product is suitable for them.
Investors understands that their principal will be at Very High risk
Nifty 500 TRI Index
Mahindra Manulife Flexi Cap Yojana
(An open ended dynamic equity scheme investing across large cap, mid cap, small cap stocks)
This Product is suitable for investors who are seeking*:
  • Long term capital appreciation.
  • Investment in diversified portfolio of equity & equity related instruments across market capitalization.
  • Investors should consult their financial advisers if in doubt about whether the product is suitable for them.
Investors understand that their principal will be at Very High risk
Nifty 500 Index TRI
Mahindra Manulife Rural Bharat and Consumption Yojana
(An open ended equity scheme following rural india theme)
This Product is suitable for investors who are seeking*:
  • Long term capital appreciation.
  • Investment predominantly in equity and equity related securities including derivatives of entities engaged in and/or expected to benefit from the growth in rural India.
  • Investors should consult their financial advisers if in doubt about whether the product is suitable for them.
Investors understands that their principal will be at Very High risk
Nifty India Consumption Index TRI
Mahindra Manulife Large Cap Pragati Yojana:
(Large Cap Fund - An open ended equity scheme predominantly investing in large cap stocks)
This Product is suitable for investors who are seeking*:
  • Long term capital appreciation.
  • Investment predominantly in equity and equity related securities including derivatives of large cap companies.
  • Investors should consult their financial advisers if in doubt about whether the product is suitable for them.
Investors understands that their principal will be at Very High risk
Nifty 100 Index TRI
Mahindra Manulife Top 250 Nivesh Yojana
(Large & Mid Cap Fund- An open ended equity scheme investing in both large cap and mid cap stocks)
This Product is suitable for investors who are seeking*:
  • Long term wealth creation and income.
  • Investment predominantly in equity and equity related securities of large and mid cap companies.
  • Investors should consult their financial advisers if in doubt about whether the product is suitable for them.
Investors understands that their principal will be at Very High risk
Nifty LargeMidcap 250 Index TRI
Mahindra Manulife Focused Equity Yojana
(An open ended equity scheme investing in maximum 30 stocks across market caps (I.e Multi Cap))
This Product is suitable for investors who are seeking*:
  • Long term capital appreciation.
  • Investment in equity and equity related instruments in concentrated portfolio of maximum 30 stocks across market capitalziation.
  • Investors should consult their financial advisers if in doubt about whether the product is suitable for them.
Investors understands that their principal will be at Very High risk
NSE 500 Index TRI
Mahindra Manulife Equity Savings Dhan Sanchay Yojana
(An open ended scheme investing in equity, arbitrage and debt)
This Product is suitable for investors who are seeking*:
  • Long term capital appreciation and generation of income.
  • Investment in equity and equity related instruments, arbitrage opportunities and debt and money market instruments.
  • Investors should consult their financial advisers if in doubt about whether the product is suitable for them.
Investors understands that their principal will be at Moderately high risk
Nifty Equity Savings Index TRI
Mahindra Manulife Hybrid Equity Nivesh Yojana
(An open ended hybrid scheme investing predominantly in equity and equity related instruments)
This Product is suitable for investors who are seeking*:
  • Long term capital appreciation and generation of income.
  • Investment in equity and equity related instruments and debt and money market instruments.
  • Investors should consult their financial advisers if in doubt about whether the product is suitable for them.
Investors understands that their principal will be at Very high risk
CRISIL Hybrid 35+65 Aggressive Index
Mahindra Manulife Balanced Advantage Yojana
(An open ended dynamic asset allocation fund)
This Product is suitable for investors who are seeking*:
  • Capital Appreciation while generating income over medium to long term.
  • Investments in a dynamically managed portfolio of equity and equity related instruments and debt and money market instruments.
  • Investors should consult their financial advisers if in doubt about whether the product is suitable for them.
Investors understand that their principal will be at Very high risk
Nifty 50 Hybrid Composite Debt 50: 50 Index TRI
Mahindra Manulife Low Duration Fund
(An open ended low duration debt scheme investing in instruments such that the Macaulay duration of the Portfolio is between 6 months and 12 months(please refer to page no. 33 of SID). A relatively low interest rate risk and moderate credit risk)
This Product is suitable for investors who are seeking*:
  • Regular Income over short term.
  • Investment in debt and money market instruments.
  • Investors should consult their financial advisers if in doubt about whether the product is suitable for them.
Investors understands that their principal will be at Moderate risk
CRISIL Low Duration Fund BI Index
Mahindra Manulife Ultra Short Term Fund
(An open ended ultra-short term debt scheme investing in instruments such that the Macaulay duration of the portfolio is between 3 to 6 months(please refer to page no. 31 of SID). A relatively low interest rate risk and moderate credit risk)
This Product is suitable for investors who are seeking*:
  • Regular Income over short term.
  • Investment in a portfolio of short term debt and money market instruments.
  • Investors should consult their financial advisers if in doubt about whether the product is suitable for them.
Investors understand that their principal will be at Moderate risk
CRISIL Ultra Short Duration Fund BI Index
Mahindra Manulife Liquid Fund
(An open ended liquid scheme. A relatively low interest rate risk and moderate credit risk)
This Product is suitable for investors who are seeking*:
  • Regular income over short term.
  • Investment in money market and debt instruments.
  • Investors should consult their financial advisers if in doubt about whether the product is suitable for them.
Investors understands that their principal will be at Low to Moderate risk
CRISIL Liquid Fund BI Index
Mahindra Manulife Dynamic Bond Yojana
(An open ended dynamic debt scheme investing across duration. A relatively high interest rate risk and moderate credit risk)
This Product is suitable for investors who are seeking*:
  • To generate regular returns and capital appreciation through active management of portfolio.
  • Investments in debt & money market instruments across duration.
  • Investors should consult their financial advisers if in doubt about whether the product is suitable for them.
Investors understands that their principal will be at Moderate risk
CRISIL Dynamic Bond Fund BIII Index
Mahindra Manulife Short Term Fund
(An open ended short term debt scheme investing in instruments such that the Macaulay duration of the portfolio is between 1 year and 3 years(please refer to page no. 36 of SID). A moderate interest rate risk and moderate credit risk)
This Product is suitable for investors who are seeking*:
  • Income over short to medium term.
  • Investment in debt and money market instruments.
  • Investors should consult their financial advisers if in doubt about whether the product is suitable for them.
Investors understands that their principal will be at Moderate risk
CRISIL Short Duration Fund BII Index
Disclaimer

The views expressed here in this document are for general information and reading purpose only and do not constitute any guidelines and recommendations on any course of action to be followed by the reader. No representation or intended to be an offer or solicitation for the purchase or sale of any financial product or instrument or mutual fund units for the reader. This document has been prepared on the basis of publicly available information, internally developed data and other sources believed to be reliable. While utmost care has been exercised while preparing this document, Mahindra Manulife Investment Management Private Limited (Formerly known as Mahindra Asset Management Company Private Limited) (AMC) does not warrant the completeness or accuracy of the information and disclaims all liabilities, losses and damages arising out of the use of this information. The data/statistics given in the document are to explain general market trends in the securities market, it should not be construed as any research report/research recommendation. Readers of this document should rely on information /data arising out of their own investigations and advised to seek independent professional advice and arrive at an informed decision before making any investments. Neither Mahindra Manulife Mutual Fund, the AMC nor Mahindra Manulife Trustee Private Limited (Formerly known as Mahindra Trustee Company Private Limited) its directors or associates shall be liable for any damages that may arise from the use of the information contained herein.

Cno.01334

Mutual Fund investments are subject to market risks, read all scheme related documents carefully.